alexa Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Materials Science

Materials Science

Journal of Nanomedicine & Nanotechnology

Author(s): Jamulitrat S, Arunpan P, Phainuphong P

Abstract Share this page

Abstract BACKGROUND: Uncertainty remains concerning the mortality attributable to infections caused by imipenem-resistant acinetobacter baumannii (IRAB). The authors have sought to examine the impact of this resistance on patient mortality. OBJECTIVE: To evaluate the effects of imipenem resistance on the mortality of patients with Acinetobacter baumannii bloodstream infection. MATERIAL AND METHOD: A cohort study was conducted to compare the survival rates between patients with IRAB and imipenem-susceptible A. baumannii (ISAB) bacteremia. RESULTS: The present study shows 35 patients (52.2\%) in an IRAB group died in hospital compared to 26 patients (19.9\%) in an ISAB group (p < 0.001). Multivariate analysis using Cox's proportional hazard model for controlling the confounding effects due to the severity of underlying diseases, inappropriate antibiotic treatment, and primary source of bacteremia show no statistically significant difference in mortality rates between the two groups. CONCLUSION: The observed higher mortality rate among patients with an IRAB bloodstream infection may not be attributable to imipenem resistance but may in some part be due to a more severe illness, inappropriate antimicrobial therapy, and primary source of infection.
This article was published in J Med Assoc Thai and referenced in Journal of Nanomedicine & Nanotechnology

Recommended Conferences

  • Nano Congress for Next Generation
    August 31-September 01, 2017 Brussels,Belgium
  • Graphene & 2D Materials
    September 14-15, 2017 Edinburgh, Scotland
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version